BWXT Enters Agreement to Acquire Kinectrics, a Leading Service Provider to the Global Nuclear Market
(LYNCHBURG, Va. – Jan. 7, 2025) – BWX Technologies, Inc. (NYSE: BWXT) today announced that it has entered into an agreement to acquire Kinectrics, Inc., for approximately US$525 million, including assumption of Kinectrics’ net pension and debt liabilities, and estimated transaction expenses. Kinectrics is a leader in providing lifecycle management services for the global nuclear […]
BWXT Medical Submits Tc-99m Generator New Drug Application to FDA
Company Highlights Growing Nuclear Medicine Product Portfolio and Future Opportunities in Therapeutic Radioisotopes (OTTAWA, ON – September 13, 2022) – BWX Technologies, Inc. (NYSE: BWXT) announced today that subsidiary BWXT Medical Ltd. has submitted a new drug application to the U.S. Food and Drug Administration (FDA) to request approval of its technetium-99m (Tc-99m) generator for […]
